Yang, Deok-Hwan <br/><br/>
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma.  [electronic resource] 

 -  Annals of hematology  May 2009 
 - 425-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-008-0616-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Fluorodeoxyglucose F18<br/>Humans<br/>Lymphoma, Non-Hodgkin--diagnosis<br/>Male<br/>Metabolism<br/>Middle Aged<br/>Neoplasm, Residual--diagnosis<br/>Positron-Emission Tomography<br/>Prognosis<br/>Remission Induction<br/>Survival Analysis<br/>T-Lymphocytes<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Young Adult